US3870051A - Urinary control - Google Patents
Urinary control Download PDFInfo
- Publication number
- US3870051A US3870051A US354910A US35491073A US3870051A US 3870051 A US3870051 A US 3870051A US 354910 A US354910 A US 354910A US 35491073 A US35491073 A US 35491073A US 3870051 A US3870051 A US 3870051A
- Authority
- US
- United States
- Prior art keywords
- muscle
- bladder
- intensity
- signals
- muscles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000002485 urinary effect Effects 0.000 title claims abstract description 26
- 210000003205 muscle Anatomy 0.000 claims abstract description 106
- 210000005070 sphincter Anatomy 0.000 claims abstract description 39
- 210000000273 spinal nerve root Anatomy 0.000 claims abstract description 26
- 210000003708 urethra Anatomy 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 21
- 241000288906 Primates Species 0.000 claims description 16
- 230000004936 stimulating effect Effects 0.000 claims description 13
- 230000008602 contraction Effects 0.000 claims description 9
- 210000005036 nerve Anatomy 0.000 claims description 9
- 230000002401 inhibitory effect Effects 0.000 claims description 8
- 230000004044 response Effects 0.000 claims description 7
- 238000002513 implantation Methods 0.000 claims description 6
- 230000003213 activating effect Effects 0.000 claims description 5
- 230000001953 sensory effect Effects 0.000 claims description 5
- 210000002700 urine Anatomy 0.000 claims description 5
- 238000004891 communication Methods 0.000 claims description 3
- 239000000835 fiber Substances 0.000 claims description 3
- 230000000541 pulsatile effect Effects 0.000 claims description 2
- 230000000638 stimulation Effects 0.000 abstract description 16
- 230000009471 action Effects 0.000 abstract description 7
- 206010021639 Incontinence Diseases 0.000 abstract description 2
- 238000011161 development Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 230000000926 neurological effect Effects 0.000 description 3
- 230000027939 micturition Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- 241001504519 Papio ursinus Species 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000003699 striated muscle Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36007—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of urogenital or gastrointestinal organs, e.g. for incontinence control
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/25—Artificial sphincters and devices for controlling urinary incontinence
Definitions
- the invention more particularly, but not exclusively, concerns urinary control for persons having disorders of neurological origin whereby they are unable to empty urine from the bladder by normal action of the bladder muscle, or unable to retain urine in the bladder by normal action of the sphincter, or, as is often the case, are unable to do either.
- the present invention affords similar urinary control by stimulation of the relevant muscles through electrodes implanted in the associated parts of the sacral ventral roots, normally numbers three and four, left and right.
- the muscles in question will be referred to hereinafter for convenience simply as the bladder muscle and the sphincter muscle.
- the former is intended to denote the detrusor muscle of the bladder, and the latter all of those striated muscles that contribute to closing the urethra.
- the principal one of these last muscles is the external sphincter of the urethra, but other pelvic muscles are also considered to be involved.
- An advantage of the presently proposed control is that the sacral ventral roots are free from sensory fibres with the result that stimulation is unlikely to lead to painJAlso, it is more economic in terms of power requirements to stimulate the sacral ventral roots than the muscles directly or the motor nerve fibres in them.
- the sacral ventral'roots in question comprise tightly packed bundles including those which govern the activity of the bladder muscle and those which govern the activity of the sphincter muscle. Accordingly, unless it proves possible to separate the respective fibres, and this seems an impossible task on the basis of existing knowledge, it is necessary to adopt a mode of differential stimulation.
- the invention involves one mode of differential stimulation which stems from the fact that the bladder muscle relaxes slowly after stimulation to contraction, while the sphincter muscle relaxes very rapidly in comparison.
- each active signal will normally comprise a pulse train and the relevant interruption period is the inter-train interval.
- Another mode of differential stimulation stems from the fact that the sacral ventral root fibres governing the activity of the bladder muscle are small compared to those for the sphincter muscle, and it follows that the latter fibres are more sensitive to electrical stimulation than theformer. Thus, it ispossible to stimulate the fibres at an intensity which causes contraction of the sphincter muscle but not the bladder muscle. Again, this stimulation will normally involve the use of a pulse train signal.
- the power requirements for the two modes of stimulation are sufficiently low, namely, low intensity for long durations and high intensity for short durations, that implantation of suitable micro-circuits with battery power supplies is possible.
- This can be effected by use of a radio transmitter/receiver arrangement as more generally de scribed in US. Pat. No. 3,699,970 whereby an externally located transmitter is operated to energise an implanted receiver.
- the use of such arrangements would allow both the hold and empty modes of control to be individually powered from without the body and so obviate the need for any implantation of power supplies.
- the present development has involved implementation with a compromise between these effective extremes of maximum and minimum implantation.
- the hold mode of control is provided by way of total implantation, and the empty mode by way of a transmitter/receiver arrangement which also serves to inhibit the hold mode.
- This overall arrangement is presently considered to represent an optimum in convenience to the beneficiary.
- the illustrated embodiment is in two parts denoted at 10 and 11 of which the first is implantable and the second employed externally of the body. Also these two parts 10 and 11 are themselves functionally subdivided into portions 10A, 10B and 11A, 118, although thissubdivision does not necessarily involve physical separation.
- the implantable portion A is the circuit which provides the hold mode of control referred to above and comprises a complementary multivibrator stage operable to generate a pulse train of twenty pulses per second which are applied through a buffer stage 21 and output stage 22 to stimulating electrodes 23A.
- the electrodes 23A are located adjacent the relevant ventralsacral roots by use of electrode terminal devices such as describedin US. Pat. No.
- resistor RlA 3718,134 and the tissue load at the electrodes is denoted by broken line resistor RlA;
- This circuit is powered by a mercury cell 24, resistor R2 in the multivibrator stage is chosen so that fifty microsecond pulses are generated, and the potentiometer R3 affords adjustment of the output pulse intensity to a low level at which only the sphincter mus cle is contracted.
- Potentiometer R3 is preferably ad- 'justable post-operatively from without the body and this can be effected by use of a magnetic coupling.
- the remaining components of the relevant circuit constitute an inhibiting stage 25 in the form of a simple radio receiver which is actuated in response to the external portion 11A to hold the multivibrator transistor switched off.
- the implantable portion 108 is also of simple radio receiver form and serves, in response to the external portion 11B, to energise further stimulating electrodes 238, in response to the external portion 11B.
- the external portions 11A, 11B are radio transmitters and it is unnecessary to consider more detailed circuit design since these portions can be of any suitable form to serve the relevant function requirements.
- the portion 118 which as mentioned earlier is to provide a relatively high intensity, interrupted pulse train signal.
- the portion 118 comprised two multivibrators connected in cascade, with the first activating the second for a period of 120 milliseconds each 1 /2 seconds, the second generating 12 /2 millisecond pulses at 9 /2 milliseconds separation during each period of activation, and the last-mentioned pulses gating the radio frequency output of the relevant transmitter.
- portion 11A which is operated at the same time as portion 118 to provide a radio signal .to inhibit the portion 10A.
- a method of urinary control which comprises applying an electricalsignal of continuous pulse train form to'the sacralventral roots,.said sacral ventral roots communicating with the sphincter muscle and bladder muscle, thereby causing the step of contracting said sphincter muscle while said bladder muscle is relaxed.
- each of said pulse trains comprises pulses of about /2 millisecond duration each 10 milliseconds.
- a method of urinary control which comprises alternatively applying two different pulsatile electrical signals to the sacral ventral roots, said sacral ventral roots communicating with the sphincter muscle and bladder muscle to thereby cause the step of stimulating said muscles, one of said signals being of lower intensity and higher repetition rate for causing the step of contracting said sphincter muscle while said bladder muscle is relaxed, and the other signal being of higher intensity and lower repetition rate for causing the step of contraction of both of said muscles during each pulse and to cause the further step of maintaining said bladder muscle contracted during part of successive interpulse periods when said sphincter muscle is relaxed.
- a method of urinary control in primates comprising:
- the signals are of a first intensity for the step of contracting the urethra closing muscles, but not contracting the bladder detrusor muscle, and including the step of spacing the first intensity pulses such that the urethra closing muscles do not become substantially relaxed between pulses;
- the signals are of a second intensity higher than said first intensity signals for causing the step of contracting both the urethra closing muscles and the bladder detrusor muscle
- electrode means disposed for stimulating the third and fourth, left and right sacral ventral motor nerve fibre roots, without substantially stimulating sensory nerve fibres;
- multivibrator means and an electrical power supply therefor for emitting said first intensity signals and a connection for communicating these signals to said electrode means;
- receiver means for receiving a command signal from outside the subject primate and connected to the inhibiting means for commanding same;
- multivibrator means for emitting said second intensity signals and a connection for communicating these signals to said electrode means
- receiver means for receiving a command signal from outside the subject primate and connected to the multivibrator means to emit said second intensity signals
- changing modes from the first to the second comprises: sending command signals from outside the subject primate to the receiver means of (d) and to the receiver means of (f); and
- the implanted multivibrator means of (b) includes electrical output intensity adjustment means and the method further comprises: post operatively adjusting the intensity of signals provided by the implanted multivibrator means of (b) by adjusting the intensity adjustment means to ensure desired first mode operation wherein there occurs contraction of the striated, sphincter muscles which contribute to closing the urethra without substantially contracting the bladder detrusor muscle.
- Urinary control apparatus comprising:
- a. stimulating electrode devices adapted for connection to the sacral ventral roots
- a first electrical circuit means operable to generate a low intensity, continuous pulse train signal, which circuit means is connected to said electrode devices to energize the same;
- a second electrical circuit means operable to generate a high intensity, interrupted pulse train signal, which circuit means is connected to said electrode devices to energize the same;
- said electrode devices and at least part of both said first and second circuit means being adapted for bodily implantation, and at least part of said activating means being for use outside the body.
- Urinary control apparatus comprising:
- a, stimulating electrode devices adapted for connection to the sacral ventral roots
- an implantable electric circuit means including a power source, operable to generate a low intensity continuous pulse train signal, which circuit means is connected to said electrode devices to energize the same;
- radio transmitter means for use outside the body operable to generate a first signal including at least a high intensity interrupted pulse train and a second signal;
- an implantable second radio receiver means operable in response to said second signal and connected to said electric circuit to inhibit operation of the same.
- Apparatus for effecting urinary control in primates by applying pulsing electrical signals to the sacral ventral roots which control contraction of the detrusor muscle for the bladder and the striated, sphincter muscles which contribute to closing the urethra, in two different modes;
- the signals are of a low intensity so as to contract the urethra closing muscles, but not to contract the bladder detrusor muscle, and wherein these low intensity signals are of such spacing between pulses that the urethra closing muscles do not become substantially relaxed between pulses;
- the signals are of a different intensity higher than said low intensity signals so as to contract both the urethra closing muscles and the bladder detrusor muscle, but of such spacing between pulses, that the urethra closing muscles, but not the bladder detrusor muscle become sufficiently relaxed between pulses, that pressure exerted on the bladder by the detrusor muscle in between pulses when the urethra closing muscles have relaxed, forces urine from the bladder and out through the urethra;
- said apparatus comprising a surgical implant which includes:
- a. electrode means being disposed, when implanted,
- multivibrator means including an electrical power supply therefor, for emitting said low intensity signals and a connection for communicating these signals to said electrode means;
- receiver means for receiving the first command signal from outside the subject primate and connected to the inhibiting means for controlling same;
- multivibrator means for emitting said higher intensity signals and a connection for communicating these signals to said electrode means
- receiver means for receiving a second command signal from outside the subject primate and connected to the multivibrator means of (e) for commanding and powering that multivibrator means to emit said higher intensity signals;
- apparatus further comprising external transmitter means for sending said first and second command signals
Landscapes
- Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Electrotherapy Devices (AREA)
- Prostheses (AREA)
- External Artificial Organs (AREA)
Abstract
Urinary control by electrical stimulation of the sphincter and bladder muscles is effected by way of the sacral ventral roots, selection in the resultant muscle action being effected by use of discriminating signal forms. Sphincter closure action is effected by use of a low intensity pulse train whereby the sphincter is stimulated but not the bladder and so incontinence is avoided. Bladder muscle action to cause micturation is effected by use of a higher intensity pulse train whereby both muscles are stimulated during each pulse train, but during each interruption the sphincter relaxes while the bladder remains contracted.
Description
United States Patent 1191 Brindley Mar. 11, 1975 1 URINARY CONTROL 3,650,276 3/1972 Brughele et a1. 128/419 1-: 3,667,477 6 1972 S t l. 128 419 E [75] Inventor: Giles Skey Brindley, London, usse et a I England Przmary Exammer--W1ll1am E. Kamm [73] Assignee: National Research Development Attorney, Agent, or FirmCushman, Darby &
Corporation, London, England Cushman 22 Pl d: A 26, 1973 1 pr 57 ABSTRACT [2]] Appl' 354910 Urinary control by electrical stimulation of the sphincter and bladder muscles is effected by way of the sa- [30] Foreign Application Priority Data cral ventral roots, selection in the resultant muscle ac- Apr. 27, 1972 Great Britain 19583/72 tion being effected y use of discriminating Signal forms. Sphincter closure action is effected b use of a y 5 Clmmu 128/422, 128/419 5, 128/1316 25 low mtensity pulse train whereby the sphincter is stim- 511 1111. C1 A61n 1/36 but not the bladder and so incontinence is [58] Field of Search U 128/419 E, 419 R, 42] avoided; Bladder muscle action to cause micturation is 128/422v DIG. 25 effected by use of a higher intensity pulse train whereby both muscles are stimulated during each [56] References Cited pulse train, but during each interruption the sphincter UNITED STATES PATENTS relaxes while the bladder remains contracted. 3.236.240 2/l966 Bradley 128/419 E 12 Claims, 1 Drawing Figure 1 l 7 i I H M L 53 H5 2 2 i C a w J A: B6 E R9 772 B7 247 I? 4 'vv/ 23A l X as? B5 1 1 71/1 R/B'Z J C1 r 5 i l 1 l i 3 l TRANSMITTER/ 775 7/) INITIATING HIGH INTENSITY SHORT BURST PULSING\ INHIBITING LOW INTENSITY STEADY PULSING i l g/TRANSMTTER URINARY CONTROL BACKGROUND OF THE INVENTION This invention concerns urinary control and more particularly such control involving electrical stimula tion by way of implanted electrodes. Also, the invention more particularly, but not exclusively, concerns urinary control for persons having disorders of neurological origin whereby they are unable to empty urine from the bladder by normal action of the bladder muscle, or unable to retain urine in the bladder by normal action of the sphincter, or, as is often the case, are unable to do either.
Various attempts have been made in the past to effect urinary control in the presence of such disorders by direct stimulation of appropriate muscles through electrodes implanted on the muscle to stimulate the as sociated motor nerve fibres. However, relatively large currents are required to effect the desired muscle contractions and, because the relevant motor nerve fibres are normally in close proximity with sensory fibres, stimulation is frequently associated with pain.
SUMMARY OF THE INVENTION In a more general aspect, the present invention, on the other hand, affords similar urinary control by stimulation of the relevant muscles through electrodes implanted in the associated parts of the sacral ventral roots, normally numbers three and four, left and right. The muscles in question will be referred to hereinafter for convenience simply as the bladder muscle and the sphincter muscle. The former is intended to denote the detrusor muscle of the bladder, and the latter all of those striated muscles that contribute to closing the urethra. The principal one of these last muscles is the external sphincter of the urethra, but other pelvic muscles are also considered to be involved.
An advantage of the presently proposed control is that the sacral ventral roots are free from sensory fibres with the result that stimulation is unlikely to lead to painJAlso, it is more economic in terms of power requirements to stimulate the sacral ventral roots than the muscles directly or the motor nerve fibres in them.
However, the sacral ventral'roots in question comprise tightly packed bundles including those which govern the activity of the bladder muscle and those which govern the activity of the sphincter muscle. Accordingly, unless it proves possible to separate the respective fibres, and this seems an impossible task on the basis of existing knowledge, it is necessary to adopt a mode of differential stimulation.
The invention involves one mode of differential stimulation which stems from the fact that the bladder muscle relaxes slowly after stimulation to contraction, while the sphincter muscle relaxes very rapidly in comparison. Thus, it is possible to stimulate the relevant fibres with electrical signals of interrupted form so that both muscles are contracted during each active signal period, while the bladder muscle remains contracted and the sphincter muscle is relaxed to afford micturition during at least a part of the signal interruption period. In practice each active signal will normally comprise a pulse train and the relevant interruption period is the inter-train interval.
Another mode of differential stimulation stems from the fact that the sacral ventral root fibres governing the activity of the bladder muscle are small compared to those for the sphincter muscle, and it follows that the latter fibres are more sensitive to electrical stimulation than theformer. Thus, it ispossible to stimulate the fibres at an intensity which causes contraction of the sphincter muscle but not the bladder muscle. Again, this stimulation will normally involve the use of a pulse train signal.
It will be normal for the purposes of the earliermentioned more particular application of the invention to employ both of these modes of differential control with the second mode being employed to hold the sphincter normally contracted except when the first mode is employed to empty the bladder.
As clarification, useful mention can be made of practical development of the invention to date. This development has led to urinary control apparatus for which the normal or hold mode involves stimulation by application of a relatively low intensity pulse train signal having a pulse repetition rate of about twenty per second, and the micturition or empty mode involves stimulation by application of a relatively high intensity, interrupted pulse train signal in which each train comprises about twelve pulses in a relatively short burst each 1 /2 seconds.
Regarding practical implementation of the invention: the power requirements for the two modes of stimulation are sufficiently low, namely, low intensity for long durations and high intensity for short durations, that implantation of suitable micro-circuits with battery power supplies is possible. However, it is necessary to provide some facility, controllable from without the body, to afford switching between the hold andempty modes of control. This can be effected by use of a radio transmitter/receiver arrangement as more generally de scribed in US. Pat. No. 3,699,970 whereby an externally located transmitter is operated to energise an implanted receiver. Indeed, the use of such arrangements would allow both the hold and empty modes of control to be individually powered from without the body and so obviate the need for any implantation of power supplies.
In practice the present development has involved implementation with a compromise between these effective extremes of maximum and minimum implantation. In this compromise, the hold mode of control is provided by way of total implantation, and the empty mode by way of a transmitter/receiver arrangement which also serves to inhibit the hold mode. This overall arrangement is presently considered to represent an optimum in convenience to the beneficiary.
BRIEF DESCRIPTION OF THE DRAWING For completeness in providing a clear understanding of the invention, one embodiment of the lastmentioned overall arrangement is illustrated, partly in diagrammatic form and partly in circuit diagram form, in the accompanying drawing. This embodiment has been successfully tested in animal trials with a baboon and is considered applicable to man.
DETAILED DESCRIPTION OF A PRESENTL PREFERRED EMBODIMENT The illustrated embodiment is in two parts denoted at 10 and 11 of which the first is implantable and the second employed externally of the body. Also these two parts 10 and 11 are themselves functionally subdivided into portions 10A, 10B and 11A, 118, although thissubdivision does not necessarily involve physical separation.
The implantable portion A is the circuit which provides the hold mode of control referred to above and comprises a complementary multivibrator stage operable to generate a pulse train of twenty pulses per second which are applied through a buffer stage 21 and output stage 22 to stimulating electrodes 23A. The electrodes 23A are located adjacent the relevant ventralsacral roots by use of electrode terminal devices such as describedin US. Pat. No. 3,718,134 and the tissue load at the electrodes is denoted by broken line resistor RlA; This circuit is powered by a mercury cell 24, resistor R2 in the multivibrator stage is chosen so that fifty microsecond pulses are generated, and the potentiometer R3 affords adjustment of the output pulse intensity to a low level at which only the sphincter mus cle is contracted. Potentiometer R3 is preferably ad- 'justable post-operatively from without the body and this can be effected by use of a magnetic coupling.
The remaining components of the relevant circuit constitute an inhibiting stage 25 in the form of a simple radio receiver which is actuated in response to the external portion 11A to hold the multivibrator transistor switched off.
The implantable portion 108 is also of simple radio receiver form and serves, in response to the external portion 11B, to energise further stimulating electrodes 238, in response to the external portion 11B.
As will be apparent from the above discussion, the external portions 11A, 11B are radio transmitters and it is unnecessary to consider more detailed circuit design since these portions can be of any suitable form to serve the relevant function requirements.
The more complex of these requirements is for the portion 118 which as mentioned earlier is to provide a relatively high intensity, interrupted pulse train signal. In the development in question the portion 118 comprised two multivibrators connected in cascade, with the first activating the second for a period of 120 milliseconds each 1 /2 seconds, the second generating 12 /2 millisecond pulses at 9 /2 milliseconds separation during each period of activation, and the last-mentioned pulses gating the radio frequency output of the relevant transmitter.
The more simple requirement is for the portion 11A which is operated at the same time as portion 118 to provide a radio signal .to inhibit the portion 10A.
Component values in the illustrated circuits are as follows:
While the invention has been described, and indeed developed so far, with reference to urinarycontrol in respect of disorders of neurological origin, the invention may afford similar control in respect of disorders of non-neurological origin, such as urinary incontinence arising from gynaecological defects. By the same token, it will be appreciated that use of both of the above-discussed more specific modes of control is not essential in all applications of the invention.
We claim:
l. A method of urinary control which comprises applying an electricalsignal of continuous pulse train form to'the sacralventral roots,.said sacral ventral roots communicating with the sphincter muscle and bladder muscle, thereby causing the step of contracting said sphincter muscle while said bladder muscle is relaxed. i i
2. A method according to claim 1 wherein said pulse 3 train has a pulse repetition rate of about 20 per second.
3. A method of urinary control which comprises applying an electrical signal of interrupted pulse train form'to the sacral ventral roots, said sacral ventral roots communicating with the sphincter muscle and bladder muscle, thereby causing the step of contracting both of said muscles during each pulse train and the further step of maintaining said bladder muscle contracted during part of each interruption period between successive pulse trains when said sphincter muscle is relaxed.
4. A method according to claim 3 wherein said pulse trains are of short duration during successive intervals of about 1 /2 seconds, and each comprise about twelve pulses.
5. A method according to claim 4 wherein each of said pulse trains comprises pulses of about /2 millisecond duration each 10 milliseconds.
6. A method of urinary control which comprises alternatively applying two different pulsatile electrical signals to the sacral ventral roots, said sacral ventral roots communicating with the sphincter muscle and bladder muscle to thereby cause the step of stimulating said muscles, one of said signals being of lower intensity and higher repetition rate for causing the step of contracting said sphincter muscle while said bladder muscle is relaxed, and the other signal being of higher intensity and lower repetition rate for causing the step of contraction of both of said muscles during each pulse and to cause the further step of maintaining said bladder muscle contracted during part of successive interpulse periods when said sphincter muscle is relaxed.
7. A method of urinary control in primates, comprising:
applying pulsing electrical signals to the sacral ventral roots which control contraction of the detrusor muscle for the bladder and the striated, sphincter muscles which contribute to closing the urethra, in two different modes;
in the first of which, the signals are of a first intensity for the step of contracting the urethra closing muscles, but not contracting the bladder detrusor muscle, and including the step of spacing the first intensity pulses such that the urethra closing muscles do not become substantially relaxed between pulses; and
in the second of which, the signals are of a second intensity higher than said first intensity signals for causing the step of contracting both the urethra closing muscles and the bladder detrusor muscle,
' and including the step of spacing the second intensity pulses such that the urethra closing muscles, but not the bladder detrusor muscle become relaxed between pulses, such that pressure exerted on the bladder by the detrusor muscle in between pulses when the urethra closing muscles have relaxed, forces urine from the bladder and out through the urethra.
8. The method of claim 7, wherein the applying step comprises:
implanting in the subject primate:
a. electrode means disposed for stimulating the third and fourth, left and right sacral ventral motor nerve fibre roots, without substantially stimulating sensory nerve fibres;
b. multivibrator means and an electrical power supply therefor, for emitting said first intensity signals and a connection for communicating these signals to said electrode means;
c. inhibiting means for preventing communication of said first intensity signals to said electrode means upon command;
d. receiver means for receiving a command signal from outside the subject primate and connected to the inhibiting means for commanding same;
e. multivibrator means for emitting said second intensity signals and a connection for communicating these signals to said electrode means;
f. receiver means for receiving a command signal from outside the subject primate and connected to the multivibrator means to emit said second intensity signals;
wherein changing modes from the first to the second comprises: sending command signals from outside the subject primate to the receiver means of (d) and to the receiver means of (f); and
wherein changing modes from the second to the first comprises: terminating the sending of said command signals from outside the subject primate.
9. The method of claim 8, wherein: the implanted multivibrator means of (b) includes electrical output intensity adjustment means and the method further comprises: post operatively adjusting the intensity of signals provided by the implanted multivibrator means of (b) by adjusting the intensity adjustment means to ensure desired first mode operation wherein there occurs contraction of the striated, sphincter muscles which contribute to closing the urethra without substantially contracting the bladder detrusor muscle.
10. Urinary control apparatus comprising:
a. stimulating electrode devices adapted for connection to the sacral ventral roots;
b. a first electrical circuit means operable to generate a low intensity, continuous pulse train signal, which circuit means is connected to said electrode devices to energize the same;
c. a second electrical circuit means operable to generate a high intensity, interrupted pulse train signal, which circuit means is connected to said electrode devices to energize the same; and
d. means for alternatively activating said first and second circuit means to energize said electrode devices;
e. said electrode devices and at least part of both said first and second circuit means being adapted for bodily implantation, and at least part of said activating means being for use outside the body.
11. Urinary control apparatus comprising:
a, stimulating electrode devices adapted for connection to the sacral ventral roots;
b. an implantable electric circuit means, including a power source, operable to generate a low intensity continuous pulse train signal, which circuit means is connected to said electrode devices to energize the same;
c. radio transmitter means for use outside the body operable to generate a first signal including at least a high intensity interrupted pulse train and a second signal;
d. an implantable first radio receiver means operable in response to said interrupted pulse train and connected to said electrode devices to energize the same; and
e. an implantable second radio receiver means operable in response to said second signal and connected to said electric circuit to inhibit operation of the same.
12. Apparatus for effecting urinary control in primates by applying pulsing electrical signals to the sacral ventral roots which control contraction of the detrusor muscle for the bladder and the striated, sphincter muscles which contribute to closing the urethra, in two different modes;
in the first of which, the signals are of a low intensity so as to contract the urethra closing muscles, but not to contract the bladder detrusor muscle, and wherein these low intensity signals are of such spacing between pulses that the urethra closing muscles do not become substantially relaxed between pulses; and
in the second of which, the signals are of a different intensity higher than said low intensity signals so as to contract both the urethra closing muscles and the bladder detrusor muscle, but of such spacing between pulses, that the urethra closing muscles, but not the bladder detrusor muscle become sufficiently relaxed between pulses, that pressure exerted on the bladder by the detrusor muscle in between pulses when the urethra closing muscles have relaxed, forces urine from the bladder and out through the urethra;
said apparatus comprising a surgical implant which includes:
a. electrode means being disposed, when implanted,
to stimulate the third and fourth, left and right sacral ventral motor nerve fibre roots, without substantially stimulating sensory nerve fibres;
b. multivibrator means including an electrical power supply therefor, for emitting said low intensity signals and a connection for communicating these signals to said electrode means;
0. inhibiting means for preventing communication of said low intensity signals to said electrode means upon the occurrence of a first command signal;
d. receiver means for receiving the first command signal from outside the subject primate and connected to the inhibiting means for controlling same;
e. multivibrator means for emitting said higher intensity signals and a connection for communicating these signals to said electrode means;
f. receiver means for receiving a second command signal from outside the subject primate and connected to the multivibrator means of (e) for commanding and powering that multivibrator means to emit said higher intensity signals;
and said apparatus further comprising external transmitter means for sending said first and second command signals;
whereby, the sending of command signals from outside the subject primate to the receiver means of (d) and to the receiver means of (f) places urinary control in the second mode thereof and terminating the sending of said command signals places urinary control in the first mode thereof.
Claims (12)
1. A method of urinary control which comprises applying an electrical signal of continuous pulse train form to the sacral ventral roots, said sacral ventral roots communicating with the sphincter muscle and bladder muscle, thereby causing the step of contracting said sphincter muscle while said bladder muscle is relaxed.
1. A method of urinary control which comprises applying an electrical signal of continuous pulse train form to the sacral ventral roots, said sacral ventral roots communicating with the sphincter muscle and bladder muscle, thereby causing the step of contracting said sphincter muscle while said bladder muscle is relaxed.
2. A method according to claim 1 wherein said pulse train has a pulse repetition rate of about 20 per second.
3. A method of urinary control which comprises applying an electrical signal of interrupted pulse train form to the sacral ventral roots, said sacral ventral roots communicating with the sphincter muscle and bladder muscle, thereby causing the step of contracting both of said muscles during each pulse train and the further step of maintaining said bladder muscle contracted during part of each interruption period between successive pulse trains when said sphincter muscle is relaxed.
4. A method according to claim 3 wherein said pulse trains are of short duration during successive intervals of about 1 1/2 seconds, and each comprise about twelve pulses.
5. A method according to claim 4 wherein each of said pulse trains comprises pulses of about 1/2 millisecond duration each 10 milliseconds.
6. A method of urinary control which comprises alternatively applying two different pulsatile electrical signals to the sacral ventral roots, said sacral ventral roots communicating with the sphincter muscle and bladder muscle to thereby cause the step of stimulating said muscles, one of said signals being of lower intensity and higher repetition rate for causing the step of contracting said sphincter muscle while said bladder muscle is relaxed, and the other signal being of higher intensity and lower repetition rate for causing the step of contraction of both of said muscles during each pulse and to cause the further step of maintaining said bladder muscle contracted during part of successive inter-pulse periods when said sphincter muscle is relaxed.
7. A method of urinary control in primates, comprising: applying pulsing electrical signals to the sacral ventral roots which control contraction of the detrusor muscle for the bladder and the striated, sphincter muscles which contribute to closing the urethra, in two different modes; in the first of which, the signals are of a first intensity for the step of contracting the urethra closing muscles, but not contracting the bladder detrusor muscle, and including the step of spacing the first intensity pulses such that the urethra closing muscles do not become substantially relaxed between pulses; and in the second of which, the signals are of a second intensity higher than said first intensity signals for causing the step of contracting both the urethra closing muscles and the bladder detrusor muscle, and including the step of spacing the second intensity pulses such that the urethra closing muscles, but not the bladder detrusor muscle become relaxed between pulses, such that pressure exerted on the bladder by the detrusor muscle in between pulses when the urethra closing muscles have relaxed, forces urine from the bladder and out through the urethra.
8. The method of claim 7, wherein the applying step comprises: implanting in the subject primate: a. electrode means disposed for stimulating the third and fourth, left and right sacral ventral motor nerve fibre roots, without substantially stimulating sensory nerve fibres; b. multivibrator means and an electrical power supply therefor, for emitting said first intensity signals and a connection for communicating these signals to said electrode means; c. inhibiting means for preventing communication of said first intensity signals to said electrode means upon command; d. receiver means for receiving a command signal from outside the subject primate and connected to the inhibiting means for commanding same; e. multivibrator means for emitting said second intensity signals and a connection for communicating these signals to said electrode means; f. receiver means for receiving a command signal from outside the subject primate and connected to the multivibrator means to emit said second intensity signals; wherein changing modes from the first to the second comprises: sending command signals from outside the subject primate to the receiver means of (d) and to the receiver means of (f); and wherein changing modes from the second to the first comprises: terminating the sending of said command signals from outside the subject primate.
9. The method of claim 8, wherein: the implanted multivibrator means of (b) includes electrical output intensity adjustment means and the method further comprises: post operatively adjusting the intensity of signals provided by the implanted multivibrator means of (b) by adjusting the intensity adjustment means to ensure desired first mode operation wherein thEre occurs contraction of the striated, sphincter muscles which contribute to closing the urethra without substantially contracting the bladder detrusor muscle.
10. Urinary control apparatus comprising: a. stimulating electrode devices adapted for connection to the sacral ventral roots; b. a first electrical circuit means operable to generate a low intensity, continuous pulse train signal, which circuit means is connected to said electrode devices to energize the same; c. a second electrical circuit means operable to generate a high intensity, interrupted pulse train signal, which circuit means is connected to said electrode devices to energize the same; and d. means for alternatively activating said first and second circuit means to energize said electrode devices; e. said electrode devices and at least part of both said first and second circuit means being adapted for bodily implantation, and at least part of said activating means being for use outside the body.
11. Urinary control apparatus comprising: a. stimulating electrode devices adapted for connection to the sacral ventral roots; b. an implantable electric circuit means, including a power source, operable to generate a low intensity continuous pulse train signal, which circuit means is connected to said electrode devices to energize the same; c. radio transmitter means for use outside the body operable to generate a first signal including at least a high intensity interrupted pulse train and a second signal; d. an implantable first radio receiver means operable in response to said interrupted pulse train and connected to said electrode devices to energize the same; and e. an implantable second radio receiver means operable in response to said second signal and connected to said electric circuit to inhibit operation of the same.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1958372A GB1434524A (en) | 1972-04-27 | 1972-04-27 | Urinary control apparatus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3870051A true US3870051A (en) | 1975-03-11 |
Family
ID=10131805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US354910A Expired - Lifetime US3870051A (en) | 1972-04-27 | 1973-04-26 | Urinary control |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | US3870051A (en) |
| GB (1) | GB1434524A (en) |
Cited By (112)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2493074A1 (en) * | 1980-10-23 | 1982-04-30 | Gorenje Tovarna Gospodinjske | CONTROL CIRCUIT FOR A THERAPEUTIC STIMULATOR FOR TREATMENT OF URINARY INCONTINENCE |
| WO1982001656A1 (en) * | 1980-11-20 | 1982-05-27 | Roy E Mcdonnell | Electrical control of body discharges and headaches |
| US4569351A (en) * | 1984-12-20 | 1986-02-11 | University Of Health Sciences/The Chicago Medical School | Apparatus and method for stimulating micturition and certain muscles in paraplegic mammals |
| US4585005A (en) * | 1984-04-06 | 1986-04-29 | Regents Of University Of California | Method and pacemaker for stimulating penile erection |
| EP0245547A1 (en) * | 1986-05-12 | 1987-11-19 | The Regents Of The University Of California | Electronic control system for controlling pelvic viscera via neuro-electrical stimulation |
| US4742833A (en) * | 1985-01-03 | 1988-05-10 | Richard Wolf Gmbh | Device for treating male persons suffering from urine incontinence |
| US4785828A (en) * | 1986-10-06 | 1988-11-22 | Empi, Inc. | Vaginal stimulator for controlling urinary incontinence in women |
| US4873996A (en) * | 1986-10-06 | 1989-10-17 | Empi, Inc. | Vaginal stimulator for controlling urinary incontinence in women |
| US4881526A (en) * | 1988-05-27 | 1989-11-21 | Empi, Inc. | Intravaginal electrode and stimulation system for controlling female urinary incontinence |
| US5193540A (en) * | 1991-12-18 | 1993-03-16 | Alfred E. Mann Foundation For Scientific Research | Structure and method of manufacture of an implantable microstimulator |
| US5193539A (en) * | 1991-12-18 | 1993-03-16 | Alfred E. Mann Foundation For Scientific Research | Implantable microstimulator |
| US5199430A (en) * | 1991-03-11 | 1993-04-06 | Case Western Reserve University | Micturitional assist device |
| US5291902A (en) * | 1993-01-11 | 1994-03-08 | Brent Carman | Incontinence treatment |
| US5454840A (en) * | 1994-04-05 | 1995-10-03 | Krakovsky; Alexander A. | Potency package |
| US5562717A (en) * | 1992-05-23 | 1996-10-08 | Axelgaard Manufacturing Company, Ltd. | Electrical stimulation for treatment of incontinence and other neuromuscular disorders |
| WO2000015293A1 (en) * | 1998-09-16 | 2000-03-23 | Axon Engineering, Inc. | Combined stimulation of ventral and dorsal sacral roots for control of bladder function |
| US6061596A (en) * | 1995-11-24 | 2000-05-09 | Advanced Bionics Corporation | Method for conditioning pelvic musculature using an implanted microstimulator |
| WO2001089629A1 (en) * | 2000-05-26 | 2001-11-29 | Consejo Superior De Investigaciones CientÃficas | Sacral root stimulating system by means of a radio-frequency powered implant |
| WO2001089630A1 (en) * | 2000-05-26 | 2001-11-29 | Consejo Superior De Investigaciones CientÃficas | Urination, defecation and erection control system in neuropathy patients |
| US6354991B1 (en) | 1998-10-06 | 2002-03-12 | Bio Control Medical Ltd | Incontinence treatment device |
| WO2002047760A1 (en) | 2000-12-12 | 2002-06-20 | Universite De Sherbrooke | Implantable neurostimulator |
| US6505074B2 (en) * | 1998-10-26 | 2003-01-07 | Birinder R. Boveja | Method and apparatus for electrical stimulation adjunct (add-on) treatment of urinary incontinence and urological disorders using an external stimulator |
| US20030018365A1 (en) * | 2001-07-20 | 2003-01-23 | Loeb Gerald E. | Method and apparatus for the treatment of urinary tract dysfunction |
| US20030082884A1 (en) * | 2001-10-26 | 2003-05-01 | International Business Machine Corporation And Kabushiki Kaisha Toshiba | Method of forming low-leakage dielectric layer |
| US6615085B1 (en) * | 1998-10-26 | 2003-09-02 | Birinder R. Boveja | Apparatus for adjunct (add-on) therapy of Dementia and Alzheimer's disease utilizing an implantable lead and an external stimulator |
| US6659936B1 (en) | 1999-08-04 | 2003-12-09 | University Of Melbourne | Method and apparatus for treating incontinence |
| US6712772B2 (en) | 2001-11-29 | 2004-03-30 | Biocontrol Medical Ltd. | Low power consumption implantable pressure sensor |
| US6735474B1 (en) | 1998-07-06 | 2004-05-11 | Advanced Bionics Corporation | Implantable stimulator system and method for treatment of incontinence and pain |
| US6836684B1 (en) | 1998-10-30 | 2004-12-28 | Neurocon Aps | Method to control an overactive bladder |
| US6862480B2 (en) | 2001-11-29 | 2005-03-01 | Biocontrol Medical Ltd. | Pelvic disorder treatment device |
| US20050055063A1 (en) * | 2001-07-20 | 2005-03-10 | Loeb Gerald E. | Method and apparatus for the treatment of urinary tract dysfunction |
| US20050060005A1 (en) * | 2001-03-30 | 2005-03-17 | Case Western Reserve University | Systems and methods for stimulating components in, on, or near the pudendal nerve or its branches to achieve selective physiologic responses |
| US6896651B2 (en) | 1998-10-06 | 2005-05-24 | Biocontrol Medical Ltd. | Mechanical and electrical sensing for incontinence treatment |
| US6907293B2 (en) | 2001-03-30 | 2005-06-14 | Case Western Reserve University | Systems and methods for selectively stimulating components in, on, or near the pudendal nerve or its branches to achieve selective physiologic responses |
| US20050143783A1 (en) * | 2003-05-11 | 2005-06-30 | Boveja Birinder R. | Method and system for providing pulsed electrical stimulation to sacral plexus of a patient to provide therapy for urinary incontinence and urological disorders |
| US6941171B2 (en) | 1998-07-06 | 2005-09-06 | Advanced Bionics Corporation | Implantable stimulator methods for treatment of incontinence and pain |
| US20050216069A1 (en) * | 2001-11-29 | 2005-09-29 | Biocontrol Medical Ltd. | Pelvic disorder treatment device |
| US20050228451A1 (en) * | 1998-07-06 | 2005-10-13 | Jaax Kristen N | Methods and systems for treating chronic pelvic pain |
| US20050251212A1 (en) * | 2000-09-27 | 2005-11-10 | Cvrx, Inc. | Stimulus regimens for cardiovascular reflex control |
| US20050278000A1 (en) * | 2004-06-10 | 2005-12-15 | Strother Robert B | Implantable pulse generator for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue |
| US20050288729A1 (en) * | 2004-06-08 | 2005-12-29 | Imad Libbus | Coordinated therapy for disordered breathing including baroreflex modulation |
| US20060004421A1 (en) * | 2004-02-12 | 2006-01-05 | Bennett Maria E | Systems and methods for bilateral stimulation of left and right branches of the dorsal genital nerves to treat dysfunctions, such as urinary incontinence |
| US20060111626A1 (en) * | 2003-03-27 | 2006-05-25 | Cvrx, Inc. | Electrode structures having anti-inflammatory properties and methods of use |
| US7054689B1 (en) | 2000-08-18 | 2006-05-30 | Advanced Bionics Corporation | Fully implantable neurostimulator for autonomic nerve fiber stimulation as a therapy for urinary and bowel dysfunction |
| US7062330B1 (en) * | 1998-10-26 | 2006-06-13 | Boveja Birinder R | Electrical stimulation adjunct (Add-ON) therapy for urinary incontinence and urological disorders using implanted lead stimulus-receiver and an external pulse generator |
| US7142925B1 (en) * | 1998-09-16 | 2006-11-28 | Axon Engineering, Inc. | Combined stimulation of ventral and dorsal sacral roots for control of bladder function |
| US20070021796A1 (en) * | 2000-09-27 | 2007-01-25 | Cvrx, Inc. | Baroreflex modulation to gradually decrease blood pressure |
| US20070038259A1 (en) * | 2000-09-27 | 2007-02-15 | Cvrx, Inc. | Method and apparatus for stimulation of baroreceptors in pulmonary artery |
| US20070060968A1 (en) * | 2004-06-10 | 2007-03-15 | Ndi Medical, Llc | Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue |
| US20070060980A1 (en) * | 2004-06-10 | 2007-03-15 | Ndi Medical, Llc | Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue |
| US20070066995A1 (en) * | 2004-06-10 | 2007-03-22 | Ndi Medical, Llc | Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue |
| US20070088400A1 (en) * | 2005-10-14 | 2007-04-19 | Jacobson Peter M | Rate responsive leadless cardiac pacemaker |
| US20070161912A1 (en) * | 2006-01-10 | 2007-07-12 | Yunlong Zhang | Assessing autonomic activity using baroreflex analysis |
| US20070161873A1 (en) * | 2002-12-04 | 2007-07-12 | Cardiac Pacemakers, Inc. | Sleep detection using an adjustable threshold |
| US20070185543A1 (en) * | 2000-09-27 | 2007-08-09 | Cvrx, Inc. | System and method for sustained baroreflex stimulation |
| US20070260288A1 (en) * | 2006-03-03 | 2007-11-08 | Yossi Gross | Apparatus for treating stress and urge incontinence |
| US20070265675A1 (en) * | 2006-05-09 | 2007-11-15 | Ams Research Corporation | Testing Efficacy of Therapeutic Mechanical or Electrical Nerve or Muscle Stimulation |
| US20070293910A1 (en) * | 2004-06-10 | 2007-12-20 | Ndi Medical, Inc. | Implantable pulse generator for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue |
| US20080009914A1 (en) * | 2006-07-10 | 2008-01-10 | Ams Research Corporation | Systems and Methods for Implanting Tissue Stimulation Electrodes in the Pelvic Region |
| US7343202B2 (en) | 2004-02-12 | 2008-03-11 | Ndi Medical, Llc. | Method for affecting urinary function with electrode implantation in adipose tissue |
| US20080161876A1 (en) * | 2006-12-21 | 2008-07-03 | Ams Research Corporation | Electrode implantation in male external urinary sphincter |
| US20080161874A1 (en) * | 2004-02-12 | 2008-07-03 | Ndi Medical, Inc. | Systems and methods for a trial stage and/or long-term treatment of disorders of the body using neurostimulation |
| US20080172101A1 (en) * | 2000-09-27 | 2008-07-17 | Cvrx, Inc. | Non-linear electrode array |
| US20090012592A1 (en) * | 2006-07-10 | 2009-01-08 | Ams Research Corporation | Tissue anchor |
| US20090082828A1 (en) * | 2007-09-20 | 2009-03-26 | Alan Ostroff | Leadless Cardiac Pacemaker with Secondary Fixation Capability |
| US20090157091A1 (en) * | 2006-04-04 | 2009-06-18 | Ams Research Corporation | Apparatus for Implanting Neural Stimulation Leads |
| US20090234418A1 (en) * | 2000-09-27 | 2009-09-17 | Kieval Robert S | Devices and methods for cardiovascular reflex control via coupled electrodes |
| US20100049289A1 (en) * | 2007-07-10 | 2010-02-25 | Ams Research Corporation | Tissue anchor |
| US20100076254A1 (en) * | 2006-06-05 | 2010-03-25 | Ams Research Corporation | Electrical muscle stimulation to treat fecal incontinence and/or pelvic prolapse |
| US7747323B2 (en) | 2004-06-08 | 2010-06-29 | Cardiac Pacemakers, Inc. | Adaptive baroreflex stimulation therapy for disordered breathing |
| US7761167B2 (en) | 2004-06-10 | 2010-07-20 | Medtronic Urinary Solutions, Inc. | Systems and methods for clinician control of stimulation systems |
| US20100198288A1 (en) * | 2009-02-02 | 2010-08-05 | Alan Ostroff | Leadless Cardiac Pacemaker with Secondary Fixation Capability |
| US20100217340A1 (en) * | 2009-02-23 | 2010-08-26 | Ams Research Corporation | Implantable Medical Device Connector System |
| US20100249874A1 (en) * | 2000-09-27 | 2010-09-30 | Bolea Stephen L | Baroreflex therapy for disordered breathing |
| US20110077708A1 (en) * | 2009-09-28 | 2011-03-31 | Alan Ostroff | MRI Compatible Leadless Cardiac Pacemaker |
| US20110160793A1 (en) * | 2009-12-31 | 2011-06-30 | Ams Research Corporation | Multi-Zone Stimulation Implant System and Method |
| US8195304B2 (en) | 2004-06-10 | 2012-06-05 | Medtronic Urinary Solutions, Inc. | Implantable systems and methods for acquisition and processing of electrical signals |
| US8467875B2 (en) | 2004-02-12 | 2013-06-18 | Medtronic, Inc. | Stimulation of dorsal genital nerves to treat urologic dysfunctions |
| US8543205B2 (en) | 2010-10-12 | 2013-09-24 | Nanostim, Inc. | Temperature sensor for a leadless cardiac pacemaker |
| US8577478B2 (en) | 2011-09-30 | 2013-11-05 | Nyxoah SA | Antenna providing variable communication with an implant |
| US8594794B2 (en) | 2007-07-24 | 2013-11-26 | Cvrx, Inc. | Baroreflex activation therapy with incrementally changing intensity |
| US8606356B2 (en) | 2003-09-18 | 2013-12-10 | Cardiac Pacemakers, Inc. | Autonomic arousal detection system and method |
| US8615310B2 (en) | 2010-12-13 | 2013-12-24 | Pacesetter, Inc. | Delivery catheter systems and methods |
| US9020611B2 (en) | 2010-10-13 | 2015-04-28 | Pacesetter, Inc. | Leadless cardiac pacemaker with anti-unscrewing feature |
| US9060692B2 (en) | 2010-10-12 | 2015-06-23 | Pacesetter, Inc. | Temperature sensor for a leadless cardiac pacemaker |
| US9126032B2 (en) | 2010-12-13 | 2015-09-08 | Pacesetter, Inc. | Pacemaker retrieval systems and methods |
| US9168383B2 (en) | 2005-10-14 | 2015-10-27 | Pacesetter, Inc. | Leadless cardiac pacemaker with conducted communication |
| US9220887B2 (en) | 2011-06-09 | 2015-12-29 | Astora Women's Health LLC | Electrode lead including a deployable tissue anchor |
| US9242102B2 (en) | 2010-12-20 | 2016-01-26 | Pacesetter, Inc. | Leadless pacemaker with radial fixation mechanism |
| US9393411B2 (en) | 2008-04-02 | 2016-07-19 | Case Western Reserve University | System and method of bladder and sphincter control |
| US9409013B2 (en) | 2009-10-20 | 2016-08-09 | Nyxoah SA | Method for controlling energy delivery as a function of degree of coupling |
| US9415216B2 (en) | 2009-10-20 | 2016-08-16 | Nyxoah SA | Devices for treatment of sleep apnea |
| US9427573B2 (en) | 2007-07-10 | 2016-08-30 | Astora Women's Health, Llc | Deployable electrode lead anchor |
| US9452287B2 (en) | 2013-01-21 | 2016-09-27 | Cala Health, Inc. | Devices and methods for controlling tremor |
| US9480846B2 (en) | 2006-05-17 | 2016-11-01 | Medtronic Urinary Solutions, Inc. | Systems and methods for patient control of stimulation systems |
| US9511236B2 (en) | 2011-11-04 | 2016-12-06 | Pacesetter, Inc. | Leadless cardiac pacemaker with integral battery and redundant welds |
| US9539433B1 (en) | 2009-03-18 | 2017-01-10 | Astora Women's Health, Llc | Electrode implantation in a pelvic floor muscular structure |
| US9731112B2 (en) | 2011-09-08 | 2017-08-15 | Paul J. Gindele | Implantable electrode assembly |
| US9802054B2 (en) | 2012-08-01 | 2017-10-31 | Pacesetter, Inc. | Biostimulator circuit with flying cell |
| US9802041B2 (en) | 2014-06-02 | 2017-10-31 | Cala Health, Inc. | Systems for peripheral nerve stimulation to treat tremor |
| US20180169409A1 (en) * | 2016-12-21 | 2018-06-21 | University Of Southern California | Smooth muscle electrical stimulation based on entrainment of intracellular calcium ion oscillations |
| US10201702B2 (en) | 2010-11-30 | 2019-02-12 | Medtronic, Inc. | Pelvic floor muscle training |
| US10765856B2 (en) | 2015-06-10 | 2020-09-08 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation to treat tremor with detachable therapy and monitoring units |
| US10814130B2 (en) | 2016-07-08 | 2020-10-27 | Cala Health, Inc. | Dry electrodes for transcutaneous nerve stimulation |
| US11331480B2 (en) | 2017-04-03 | 2022-05-17 | Cala Health, Inc. | Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder |
| US11344722B2 (en) | 2016-01-21 | 2022-05-31 | Cala Health, Inc. | Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder |
| US11596785B2 (en) | 2015-09-23 | 2023-03-07 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation in the finger or hand to treat hand tremors |
| US11857778B2 (en) | 2018-01-17 | 2024-01-02 | Cala Health, Inc. | Systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation |
| US11890468B1 (en) | 2019-10-03 | 2024-02-06 | Cala Health, Inc. | Neurostimulation systems with event pattern detection and classification |
| US12233265B2 (en) | 2016-08-25 | 2025-02-25 | Cala Health, Inc. | Systems and methods for treating cardiac dysfunction through peripheral nerve stimulation |
| US12251560B1 (en) | 2019-08-13 | 2025-03-18 | Cala Health, Inc. | Connection quality determination for wearable neurostimulation systems |
| US12453853B2 (en) | 2013-01-21 | 2025-10-28 | Cala Health, Inc. | Multi-modal stimulation for treating tremor |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3236240A (en) * | 1962-09-06 | 1966-02-22 | Univ Minnesota | Implantable bladder stimulator |
| US3650276A (en) * | 1969-03-26 | 1972-03-21 | Inst Demedicina Si Farmacie | Method and apparatus, including a flexible electrode, for the electric neurostimulation of the neurogenic bladder |
| US3667477A (en) * | 1966-11-25 | 1972-06-06 | Canadian Patents Dev | Implantable vesical stimulator |
-
1972
- 1972-04-27 GB GB1958372A patent/GB1434524A/en not_active Expired
-
1973
- 1973-04-26 US US354910A patent/US3870051A/en not_active Expired - Lifetime
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3236240A (en) * | 1962-09-06 | 1966-02-22 | Univ Minnesota | Implantable bladder stimulator |
| US3667477A (en) * | 1966-11-25 | 1972-06-06 | Canadian Patents Dev | Implantable vesical stimulator |
| US3650276A (en) * | 1969-03-26 | 1972-03-21 | Inst Demedicina Si Farmacie | Method and apparatus, including a flexible electrode, for the electric neurostimulation of the neurogenic bladder |
Cited By (292)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2493074A1 (en) * | 1980-10-23 | 1982-04-30 | Gorenje Tovarna Gospodinjske | CONTROL CIRCUIT FOR A THERAPEUTIC STIMULATOR FOR TREATMENT OF URINARY INCONTINENCE |
| US4387719A (en) * | 1980-10-23 | 1983-06-14 | Gorenje Tovarna Gospodinjske Opreme N.Sol.O. Velenje | Control circuit of a therapeutic stimulator for the urinary incontinence |
| WO1982001656A1 (en) * | 1980-11-20 | 1982-05-27 | Roy E Mcdonnell | Electrical control of body discharges and headaches |
| US4537195A (en) * | 1980-11-20 | 1985-08-27 | Mcdonnell Roy E | Electrical control of body discharges and headaches |
| US4585005A (en) * | 1984-04-06 | 1986-04-29 | Regents Of University Of California | Method and pacemaker for stimulating penile erection |
| US4569351A (en) * | 1984-12-20 | 1986-02-11 | University Of Health Sciences/The Chicago Medical School | Apparatus and method for stimulating micturition and certain muscles in paraplegic mammals |
| US4742833A (en) * | 1985-01-03 | 1988-05-10 | Richard Wolf Gmbh | Device for treating male persons suffering from urine incontinence |
| EP0245547A1 (en) * | 1986-05-12 | 1987-11-19 | The Regents Of The University Of California | Electronic control system for controlling pelvic viscera via neuro-electrical stimulation |
| US4785828A (en) * | 1986-10-06 | 1988-11-22 | Empi, Inc. | Vaginal stimulator for controlling urinary incontinence in women |
| US4873996A (en) * | 1986-10-06 | 1989-10-17 | Empi, Inc. | Vaginal stimulator for controlling urinary incontinence in women |
| US4881526A (en) * | 1988-05-27 | 1989-11-21 | Empi, Inc. | Intravaginal electrode and stimulation system for controlling female urinary incontinence |
| US5199430A (en) * | 1991-03-11 | 1993-04-06 | Case Western Reserve University | Micturitional assist device |
| US5193540A (en) * | 1991-12-18 | 1993-03-16 | Alfred E. Mann Foundation For Scientific Research | Structure and method of manufacture of an implantable microstimulator |
| US5193539A (en) * | 1991-12-18 | 1993-03-16 | Alfred E. Mann Foundation For Scientific Research | Implantable microstimulator |
| US5324316A (en) * | 1991-12-18 | 1994-06-28 | Alfred E. Mann Foundation For Scientific Research | Implantable microstimulator |
| US5562717A (en) * | 1992-05-23 | 1996-10-08 | Axelgaard Manufacturing Company, Ltd. | Electrical stimulation for treatment of incontinence and other neuromuscular disorders |
| US5291902A (en) * | 1993-01-11 | 1994-03-08 | Brent Carman | Incontinence treatment |
| US5454840A (en) * | 1994-04-05 | 1995-10-03 | Krakovsky; Alexander A. | Potency package |
| US6061596A (en) * | 1995-11-24 | 2000-05-09 | Advanced Bionics Corporation | Method for conditioning pelvic musculature using an implanted microstimulator |
| US20050228451A1 (en) * | 1998-07-06 | 2005-10-13 | Jaax Kristen N | Methods and systems for treating chronic pelvic pain |
| US7890176B2 (en) | 1998-07-06 | 2011-02-15 | Boston Scientific Neuromodulation Corporation | Methods and systems for treating chronic pelvic pain |
| US6941171B2 (en) | 1998-07-06 | 2005-09-06 | Advanced Bionics Corporation | Implantable stimulator methods for treatment of incontinence and pain |
| US6735474B1 (en) | 1998-07-06 | 2004-05-11 | Advanced Bionics Corporation | Implantable stimulator system and method for treatment of incontinence and pain |
| WO2000015293A1 (en) * | 1998-09-16 | 2000-03-23 | Axon Engineering, Inc. | Combined stimulation of ventral and dorsal sacral roots for control of bladder function |
| US7142925B1 (en) * | 1998-09-16 | 2006-11-28 | Axon Engineering, Inc. | Combined stimulation of ventral and dorsal sacral roots for control of bladder function |
| US8083663B2 (en) | 1998-10-06 | 2011-12-27 | Ams Research Corporation | Pelvic disorder treatment |
| US8340786B2 (en) | 1998-10-06 | 2012-12-25 | Ams Research Corporation | Incontinence treatment device |
| US6896651B2 (en) | 1998-10-06 | 2005-05-24 | Biocontrol Medical Ltd. | Mechanical and electrical sensing for incontinence treatment |
| US20050113881A1 (en) * | 1998-10-06 | 2005-05-26 | Yossi Gross | Incontinence treatment device |
| US6652449B1 (en) | 1998-10-06 | 2003-11-25 | Bio Control Medical, Ltd. | Control of urge incontinence |
| US7387603B2 (en) | 1998-10-06 | 2008-06-17 | Ams Research Corporation | Incontinence treatment device |
| US6354991B1 (en) | 1998-10-06 | 2002-03-12 | Bio Control Medical Ltd | Incontinence treatment device |
| US20050261746A1 (en) * | 1998-10-06 | 2005-11-24 | Yossi Gross | Control of urge incontinence |
| US20080242918A1 (en) * | 1998-10-06 | 2008-10-02 | Ams Research Corporation | Incontinence Treatment Device |
| US7582053B2 (en) | 1998-10-06 | 2009-09-01 | Ams Research Corporation | Control of urge incontinence |
| US6505074B2 (en) * | 1998-10-26 | 2003-01-07 | Birinder R. Boveja | Method and apparatus for electrical stimulation adjunct (add-on) treatment of urinary incontinence and urological disorders using an external stimulator |
| US6615085B1 (en) * | 1998-10-26 | 2003-09-02 | Birinder R. Boveja | Apparatus for adjunct (add-on) therapy of Dementia and Alzheimer's disease utilizing an implantable lead and an external stimulator |
| US7062330B1 (en) * | 1998-10-26 | 2006-06-13 | Boveja Birinder R | Electrical stimulation adjunct (Add-ON) therapy for urinary incontinence and urological disorders using implanted lead stimulus-receiver and an external pulse generator |
| US6836684B1 (en) | 1998-10-30 | 2004-12-28 | Neurocon Aps | Method to control an overactive bladder |
| US20080195172A1 (en) * | 1999-08-04 | 2008-08-14 | The University Of Melbourne | Method and apparatus for treating incontinence |
| US6659936B1 (en) | 1999-08-04 | 2003-12-09 | University Of Melbourne | Method and apparatus for treating incontinence |
| US20050119710A1 (en) * | 1999-08-04 | 2005-06-02 | Furness John B. | Method and apparatus for treating incontinence |
| US7384390B2 (en) | 1999-08-04 | 2008-06-10 | The University Of Melbourne | Method and apparatus for treating incontinence |
| ES2164017B1 (en) * | 2000-05-26 | 2004-06-01 | Consejo Superior De Investigaciones Cientificas | SACRAS ROOT STIMULATION SYSTEM THROUGH IMPLANT POWERED BY RADIO FREQUENCY. |
| ES2164017A2 (en) * | 2000-05-26 | 2002-02-01 | Consejo Superior Investigacion | Sacral root stimulating system by means of a radio-frequency powered implant |
| ES2161648A1 (en) * | 2000-05-26 | 2001-12-01 | Consejo Superior Investigacion | Urination, defecation and erection control system in neuropathy patients |
| WO2001089630A1 (en) * | 2000-05-26 | 2001-11-29 | Consejo Superior De Investigaciones CientÃficas | Urination, defecation and erection control system in neuropathy patients |
| WO2001089629A1 (en) * | 2000-05-26 | 2001-11-29 | Consejo Superior De Investigaciones CientÃficas | Sacral root stimulating system by means of a radio-frequency powered implant |
| US8214048B1 (en) * | 2000-08-18 | 2012-07-03 | Boston Scientific Neuromodulation Corporation | Fully implantable neurostimulator for autonomic nerve fiber stimulation as a therapy for urinary and bowel dysfunction |
| US8588917B2 (en) | 2000-08-18 | 2013-11-19 | Boston Scientific Neuromodulation Corporation | Fully implantable neurostimulator for autonomic nerve fiber stimulation as a therapy for urinary and bowel dysfunction |
| US7054689B1 (en) | 2000-08-18 | 2006-05-30 | Advanced Bionics Corporation | Fully implantable neurostimulator for autonomic nerve fiber stimulation as a therapy for urinary and bowel dysfunction |
| US7840271B2 (en) | 2000-09-27 | 2010-11-23 | Cvrx, Inc. | Stimulus regimens for cardiovascular reflex control |
| US8060206B2 (en) | 2000-09-27 | 2011-11-15 | Cvrx, Inc. | Baroreflex modulation to gradually decrease blood pressure |
| US20080215111A1 (en) * | 2000-09-27 | 2008-09-04 | Cvrx, Inc. | Devices and Methods for Cardiovascular Reflex Control |
| US20080177349A1 (en) * | 2000-09-27 | 2008-07-24 | Cvrx, Inc. | Apparatus and method for modulating the baroreflex system |
| US8583236B2 (en) | 2000-09-27 | 2013-11-12 | Cvrx, Inc. | Devices and methods for cardiovascular reflex control |
| US8712531B2 (en) | 2000-09-27 | 2014-04-29 | Cvrx, Inc. | Automatic baroreflex modulation responsive to adverse event |
| US20080171923A1 (en) * | 2000-09-27 | 2008-07-17 | Cvrx, Inc. | Assessing autonomic activity using baroreflex analysis |
| US8718789B2 (en) | 2000-09-27 | 2014-05-06 | Cvrx, Inc. | Electrode structures and methods for their use in cardiovascular reflex control |
| US8838246B2 (en) | 2000-09-27 | 2014-09-16 | Cvrx, Inc. | Devices and methods for cardiovascular reflex treatments |
| US8880190B2 (en) | 2000-09-27 | 2014-11-04 | Cvrx, Inc. | Electrode structures and methods for their use in cardiovascular reflex control |
| US9044609B2 (en) | 2000-09-27 | 2015-06-02 | Cvrx, Inc. | Electrode structures and methods for their use in cardiovascular reflex control |
| US20080172101A1 (en) * | 2000-09-27 | 2008-07-17 | Cvrx, Inc. | Non-linear electrode array |
| US20070021796A1 (en) * | 2000-09-27 | 2007-01-25 | Cvrx, Inc. | Baroreflex modulation to gradually decrease blood pressure |
| US20070021792A1 (en) * | 2000-09-27 | 2007-01-25 | Cvrx, Inc. | Baroreflex Modulation Based On Monitored Cardiovascular Parameter |
| US20070021794A1 (en) * | 2000-09-27 | 2007-01-25 | Cvrx, Inc. | Baroreflex Therapy for Disordered Breathing |
| US20070021799A1 (en) * | 2000-09-27 | 2007-01-25 | Cvrx, Inc. | Automatic baroreflex modulation based on cardiac activity |
| US20070021797A1 (en) * | 2000-09-27 | 2007-01-25 | Cvrx, Inc. | Baroreflex stimulation synchronized to circadian rhythm |
| US8290595B2 (en) | 2000-09-27 | 2012-10-16 | Cvrx, Inc. | Method and apparatus for stimulation of baroreceptors in pulmonary artery |
| US20070038262A1 (en) * | 2000-09-27 | 2007-02-15 | Cvrx, Inc. | Baroreflex stimulation system to reduce hypertension |
| US20070038259A1 (en) * | 2000-09-27 | 2007-02-15 | Cvrx, Inc. | Method and apparatus for stimulation of baroreceptors in pulmonary artery |
| US20070038261A1 (en) * | 2000-09-27 | 2007-02-15 | Cvrx, Inc. | Lead for stimulating the baroreceptors in the pulmonary artery |
| US9427583B2 (en) | 2000-09-27 | 2016-08-30 | Cvrx, Inc. | Electrode structures and methods for their use in cardiovascular reflex control |
| US20050251212A1 (en) * | 2000-09-27 | 2005-11-10 | Cvrx, Inc. | Stimulus regimens for cardiovascular reflex control |
| US20070060972A1 (en) * | 2000-09-27 | 2007-03-15 | Cvrx, Inc. | Devices and methods for cardiovascular reflex treatments |
| US8086314B1 (en) * | 2000-09-27 | 2011-12-27 | Cvrx, Inc. | Devices and methods for cardiovascular reflex control |
| US20090234418A1 (en) * | 2000-09-27 | 2009-09-17 | Kieval Robert S | Devices and methods for cardiovascular reflex control via coupled electrodes |
| US7949400B2 (en) | 2000-09-27 | 2011-05-24 | Cvrx, Inc. | Devices and methods for cardiovascular reflex control via coupled electrodes |
| US7623926B2 (en) | 2000-09-27 | 2009-11-24 | Cvrx, Inc. | Stimulus regimens for cardiovascular reflex control |
| US8606359B2 (en) | 2000-09-27 | 2013-12-10 | Cvrx, Inc. | System and method for sustained baroreflex stimulation |
| US7813812B2 (en) | 2000-09-27 | 2010-10-12 | Cvrx, Inc. | Baroreflex stimulator with integrated pressure sensor |
| US20100174347A1 (en) * | 2000-09-27 | 2010-07-08 | Kieval Robert S | Devices and methods for cardiovascular reflex control via coupled electrodes |
| US20100249874A1 (en) * | 2000-09-27 | 2010-09-30 | Bolea Stephen L | Baroreflex therapy for disordered breathing |
| US7801614B2 (en) | 2000-09-27 | 2010-09-21 | Cvrx, Inc. | Stimulus regimens for cardiovascular reflex control |
| US20070167984A1 (en) * | 2000-09-27 | 2007-07-19 | Cvrx, Inc. | Method and apparatus for stimulation of baroreceptors |
| US20070185543A1 (en) * | 2000-09-27 | 2007-08-09 | Cvrx, Inc. | System and method for sustained baroreflex stimulation |
| US20100191303A1 (en) * | 2000-09-27 | 2010-07-29 | Cvrx, Inc. | Automatic baroreflex modulation responsive to adverse event |
| US20100179614A1 (en) * | 2000-09-27 | 2010-07-15 | Kieval Robert S | Devices and methods for cardiovascular reflex control |
| WO2002047760A1 (en) | 2000-12-12 | 2002-06-20 | Universite De Sherbrooke | Implantable neurostimulator |
| US20040102820A1 (en) * | 2000-12-12 | 2004-05-27 | Mouine Jaouhar | Implantable neurostimulator |
| US7047078B2 (en) * | 2001-03-30 | 2006-05-16 | Case Western Reserve University | Methods for stimulating components in, on, or near the pudendal nerve or its branches to achieve selective physiologic responses |
| US6907293B2 (en) | 2001-03-30 | 2005-06-14 | Case Western Reserve University | Systems and methods for selectively stimulating components in, on, or near the pudendal nerve or its branches to achieve selective physiologic responses |
| US20050060005A1 (en) * | 2001-03-30 | 2005-03-17 | Case Western Reserve University | Systems and methods for stimulating components in, on, or near the pudendal nerve or its branches to achieve selective physiologic responses |
| US9446245B2 (en) | 2001-03-30 | 2016-09-20 | Case Western Reserve University | Systems and methods for selectively stimulating components in, on, or near the pudendal nerve or its branches to achieve selectively physiological responses |
| US7623925B2 (en) | 2001-03-30 | 2009-11-24 | Case Western Reserve University | Methods for selectively stimulating components in, on, or near the pudendal nerve or its branches to achieve selective physiologic responses |
| US20050222636A1 (en) * | 2001-03-30 | 2005-10-06 | Case Western Reserve University | Systems and methods for selectively stimulating components in, on, or near the pudendal nerve or its branches to achieve selective physiologic responses |
| WO2003007885A3 (en) * | 2001-07-20 | 2003-04-10 | Alfred E Mann Inst Biomed Eng | Method and apparatus for the treatment of urinary tract dysfunction |
| US20030018365A1 (en) * | 2001-07-20 | 2003-01-23 | Loeb Gerald E. | Method and apparatus for the treatment of urinary tract dysfunction |
| US20050055063A1 (en) * | 2001-07-20 | 2005-03-10 | Loeb Gerald E. | Method and apparatus for the treatment of urinary tract dysfunction |
| US20080097540A1 (en) * | 2001-09-26 | 2008-04-24 | Cvrx, Inc. | Ecg input to implantable pulse generator using carotid sinus leads |
| US20070106340A1 (en) * | 2001-09-26 | 2007-05-10 | Cvrx, Inc. | Electrode structures and methods for their use in cardiovascular reflex control |
| US20030082884A1 (en) * | 2001-10-26 | 2003-05-01 | International Business Machine Corporation And Kabushiki Kaisha Toshiba | Method of forming low-leakage dielectric layer |
| US20090036946A1 (en) * | 2001-11-29 | 2009-02-05 | American Medical Systems, Inc. | Pelvic disorder treatments |
| US20050049648A1 (en) * | 2001-11-29 | 2005-03-03 | Biocontrol Medical Ltd. | Pelvic disorder treatment device |
| US6712772B2 (en) | 2001-11-29 | 2004-03-30 | Biocontrol Medical Ltd. | Low power consumption implantable pressure sensor |
| US6862480B2 (en) | 2001-11-29 | 2005-03-01 | Biocontrol Medical Ltd. | Pelvic disorder treatment device |
| US20050216069A1 (en) * | 2001-11-29 | 2005-09-29 | Biocontrol Medical Ltd. | Pelvic disorder treatment device |
| US7613516B2 (en) | 2001-11-29 | 2009-11-03 | Ams Research Corporation | Pelvic disorder treatment device |
| US20070161873A1 (en) * | 2002-12-04 | 2007-07-12 | Cardiac Pacemakers, Inc. | Sleep detection using an adjustable threshold |
| US8535222B2 (en) | 2002-12-04 | 2013-09-17 | Cardiac Pacemakers, Inc. | Sleep detection using an adjustable threshold |
| US8956295B2 (en) | 2002-12-04 | 2015-02-17 | Cardiac Pacemakers, Inc. | Sleep detection using an adjustable threshold |
| US20060111626A1 (en) * | 2003-03-27 | 2006-05-25 | Cvrx, Inc. | Electrode structures having anti-inflammatory properties and methods of use |
| US7177703B2 (en) * | 2003-05-11 | 2007-02-13 | Boveja Birinder R | Method and system for providing pulsed electrical stimulation to sacral plexus of a patient to provide therapy for urinary incontinence and urological disorders |
| US20050143783A1 (en) * | 2003-05-11 | 2005-06-30 | Boveja Birinder R. | Method and system for providing pulsed electrical stimulation to sacral plexus of a patient to provide therapy for urinary incontinence and urological disorders |
| US7571000B2 (en) | 2003-09-12 | 2009-08-04 | Case Western Reserve University | Apparatus for stimulating components in, on, or near the pudendal nerve or its branches to achieve selective physiologic responses |
| WO2005032332A3 (en) * | 2003-09-12 | 2005-08-11 | Univ Case Western Reserve | Systems and methods for stimulating the pudendal nerve for achieving selective responses. |
| US20090326603A1 (en) * | 2003-09-12 | 2009-12-31 | Case Western Reserve University | Apparatus for stimulating components in, on, or near the pudendal nerve or its branches to achieve selective physiologic responses |
| US20060184208A1 (en) * | 2003-09-12 | 2006-08-17 | Case Western Reserve University | Apparatus for stimulating components in, on, or near the pudendal nerve or its branches to achieve selective physiologic responses |
| US8396555B2 (en) | 2003-09-12 | 2013-03-12 | Case Western Reserve University | Apparatus for stimulating components in, on, or near the pudendal nerve or its branches to achieve selective physiologic responses |
| US8606356B2 (en) | 2003-09-18 | 2013-12-10 | Cardiac Pacemakers, Inc. | Autonomic arousal detection system and method |
| US9014819B2 (en) | 2003-09-18 | 2015-04-21 | Cardiac Pacemakers, Inc. | Autonomic arousal detection system and method |
| US20080161874A1 (en) * | 2004-02-12 | 2008-07-03 | Ndi Medical, Inc. | Systems and methods for a trial stage and/or long-term treatment of disorders of the body using neurostimulation |
| US7565198B2 (en) | 2004-02-12 | 2009-07-21 | Medtronic Urinary Solutions, Inc. | Systems and methods for bilateral stimulation of left and right branches of the dorsal genital nerves to treat dysfunctions, such as urinary incontinence |
| US8467875B2 (en) | 2004-02-12 | 2013-06-18 | Medtronic, Inc. | Stimulation of dorsal genital nerves to treat urologic dysfunctions |
| US7343202B2 (en) | 2004-02-12 | 2008-03-11 | Ndi Medical, Llc. | Method for affecting urinary function with electrode implantation in adipose tissue |
| US8649870B2 (en) | 2004-02-12 | 2014-02-11 | Medtronic Uninary Solutions, Inc. | Systems and methods including lead and electrode structures sized and configured for implantation in adipose tissue |
| US20060004421A1 (en) * | 2004-02-12 | 2006-01-05 | Bennett Maria E | Systems and methods for bilateral stimulation of left and right branches of the dorsal genital nerves to treat dysfunctions, such as urinary incontinence |
| US20050288729A1 (en) * | 2004-06-08 | 2005-12-29 | Imad Libbus | Coordinated therapy for disordered breathing including baroreflex modulation |
| US7747323B2 (en) | 2004-06-08 | 2010-06-29 | Cardiac Pacemakers, Inc. | Adaptive baroreflex stimulation therapy for disordered breathing |
| US8442638B2 (en) | 2004-06-08 | 2013-05-14 | Cardiac Pacemakers, Inc. | Adaptive baroreflex stimulation therapy for disordered breathing |
| US9872987B2 (en) | 2004-06-08 | 2018-01-23 | Cardiac Pacemakers, Inc. | Method and system for treating congestive heart failure |
| US7596413B2 (en) | 2004-06-08 | 2009-09-29 | Cardiac Pacemakers, Inc. | Coordinated therapy for disordered breathing including baroreflex modulation |
| US9308382B2 (en) | 2004-06-10 | 2016-04-12 | Medtronic Urinary Solutions, Inc. | Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue |
| US8195304B2 (en) | 2004-06-10 | 2012-06-05 | Medtronic Urinary Solutions, Inc. | Implantable systems and methods for acquisition and processing of electrical signals |
| US8706252B2 (en) | 2004-06-10 | 2014-04-22 | Medtronic, Inc. | Systems and methods for clinician control of stimulation system |
| US20050278000A1 (en) * | 2004-06-10 | 2005-12-15 | Strother Robert B | Implantable pulse generator for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue |
| US9724526B2 (en) | 2004-06-10 | 2017-08-08 | Medtronic Urinary Solutions, Inc. | Implantable pulse generator systems and methods for operating the same |
| US9205255B2 (en) | 2004-06-10 | 2015-12-08 | Medtronic Urinary Solutions, Inc. | Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue |
| US20070293910A1 (en) * | 2004-06-10 | 2007-12-20 | Ndi Medical, Inc. | Implantable pulse generator for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue |
| US7761167B2 (en) | 2004-06-10 | 2010-07-20 | Medtronic Urinary Solutions, Inc. | Systems and methods for clinician control of stimulation systems |
| US10293168B2 (en) | 2004-06-10 | 2019-05-21 | Medtronic Urinary Solutions, Inc. | Systems and methods for clinician control of stimulation systems |
| US9216294B2 (en) | 2004-06-10 | 2015-12-22 | Medtronic Urinary Solutions, Inc. | Systems and methods for clinician control of stimulation systems |
| US10434320B2 (en) | 2004-06-10 | 2019-10-08 | Medtronic Urinary Solutions, Inc. | Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue |
| US7813809B2 (en) | 2004-06-10 | 2010-10-12 | Medtronic, Inc. | Implantable pulse generator for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue |
| US20100274324A1 (en) * | 2004-06-10 | 2010-10-28 | Medtronic Urinary Solutions, Inc. | Systems and methods for clinician control of stimulation system |
| US20070066995A1 (en) * | 2004-06-10 | 2007-03-22 | Ndi Medical, Llc | Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue |
| US20070060980A1 (en) * | 2004-06-10 | 2007-03-15 | Ndi Medical, Llc | Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue |
| US20070060968A1 (en) * | 2004-06-10 | 2007-03-15 | Ndi Medical, Llc | Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue |
| US8165692B2 (en) | 2004-06-10 | 2012-04-24 | Medtronic Urinary Solutions, Inc. | Implantable pulse generator power management |
| US20070088397A1 (en) * | 2005-10-14 | 2007-04-19 | Jacobson Peter M | Leadless cardiac pacemaker system with conductive communication |
| US20070088396A1 (en) * | 2005-10-14 | 2007-04-19 | Jacobson Peter M | Leadless cardiac pacemaker |
| US9168383B2 (en) | 2005-10-14 | 2015-10-27 | Pacesetter, Inc. | Leadless cardiac pacemaker with conducted communication |
| US20070088418A1 (en) * | 2005-10-14 | 2007-04-19 | Jacobson Peter M | Delivery system for implantable biostimulator |
| US8295939B2 (en) | 2005-10-14 | 2012-10-23 | Nanostim, Inc. | Programmer for biostimulator system |
| US20070088400A1 (en) * | 2005-10-14 | 2007-04-19 | Jacobson Peter M | Rate responsive leadless cardiac pacemaker |
| US8352025B2 (en) | 2005-10-14 | 2013-01-08 | Nanostim, Inc. | Leadless cardiac pacemaker triggered by conductive communication |
| US20070088405A1 (en) * | 2005-10-14 | 2007-04-19 | Jacobson Peter M | Programmer for biostimulator system |
| US20110218587A1 (en) * | 2005-10-14 | 2011-09-08 | Nanostim, Inc. | Programmer for Biostimulator System |
| US8010209B2 (en) | 2005-10-14 | 2011-08-30 | Nanostim, Inc. | Delivery system for implantable biostimulator |
| US8457742B2 (en) | 2005-10-14 | 2013-06-04 | Nanostim, Inc. | Leadless cardiac pacemaker system for usage in combination with an implantable cardioverter-defibrillator |
| US9227077B2 (en) | 2005-10-14 | 2016-01-05 | Pacesetter, Inc. | Leadless cardiac pacemaker triggered by conductive communication |
| US9192774B2 (en) | 2005-10-14 | 2015-11-24 | Pacesetter, Inc. | Cardiac pacemaker system for usage in combination with an implantable cardioverter-defibrillator |
| US9072913B2 (en) | 2005-10-14 | 2015-07-07 | Pacesetter, Inc. | Rate responsive leadless cardiac pacemaker |
| US10238883B2 (en) | 2005-10-14 | 2019-03-26 | Pacesetter Inc. | Leadless cardiac pacemaker system for usage in combination with an implantable cardioverter-defibrillator |
| US7945333B2 (en) | 2005-10-14 | 2011-05-17 | Nanostim, Inc. | Programmer for biostimulator system |
| US8855789B2 (en) | 2005-10-14 | 2014-10-07 | Pacesetter, Inc. | Implantable biostimulator delivery system |
| US7937148B2 (en) | 2005-10-14 | 2011-05-03 | Nanostim, Inc. | Rate responsive leadless cardiac pacemaker |
| US8798745B2 (en) | 2005-10-14 | 2014-08-05 | Pacesetter, Inc. | Leadless cardiac pacemaker system for usage in combination with an implantable cardioverter-defibrillator |
| US8788035B2 (en) | 2005-10-14 | 2014-07-22 | Pacesetter, Inc. | Leadless cardiac pacemaker triggered by conductive communication |
| US8788053B2 (en) | 2005-10-14 | 2014-07-22 | Pacesetter, Inc. | Programmer for biostimulator system |
| US9358400B2 (en) | 2005-10-14 | 2016-06-07 | Pacesetter, Inc. | Leadless cardiac pacemaker |
| US9409033B2 (en) | 2005-10-14 | 2016-08-09 | Pacesetter, Inc. | Leadless cardiac pacemaker system for usage in combination with an implantable cardioverter-defibrillator |
| US9872999B2 (en) | 2005-10-14 | 2018-01-23 | Pacesetter, Inc. | Leadless cardiac pacemaker system for usage in combination with an implantable cardioverter-defibrillator |
| US9216298B2 (en) | 2005-10-14 | 2015-12-22 | Pacesetter, Inc. | Leadless cardiac pacemaker system with conductive communication |
| US20110071586A1 (en) * | 2005-10-14 | 2011-03-24 | Nanostim, Inc. | Leadless Cardiac Pacemaker Triggered by Conductive Communication |
| US9687666B2 (en) | 2005-10-14 | 2017-06-27 | Pacesetter, Inc. | Leadless cardiac pacemaker system for usage in combination with an implantable cardioverter-defibrillator |
| US20090069738A1 (en) * | 2005-12-29 | 2009-03-12 | Cvrx, Inc. | Electrode Structures Having Anti-Inflammatory Properties And Methods Of Use |
| US8109879B2 (en) | 2006-01-10 | 2012-02-07 | Cardiac Pacemakers, Inc. | Assessing autonomic activity using baroreflex analysis |
| US20070161912A1 (en) * | 2006-01-10 | 2007-07-12 | Yunlong Zhang | Assessing autonomic activity using baroreflex analysis |
| US9949668B2 (en) | 2006-01-10 | 2018-04-24 | Cardiac Pacemakers, Inc. | Assessing autonomic activity using baroreflex analysis |
| US9889298B2 (en) | 2006-03-03 | 2018-02-13 | Astora Women's Health, Llc | Electrode sling for treating stress and urge incontinence |
| US8195296B2 (en) | 2006-03-03 | 2012-06-05 | Ams Research Corporation | Apparatus for treating stress and urge incontinence |
| US20090043356A1 (en) * | 2006-03-03 | 2009-02-12 | Ams Research Corporation | Electrode Sling for Treating Stress and Urge Incontinence |
| US20070260288A1 (en) * | 2006-03-03 | 2007-11-08 | Yossi Gross | Apparatus for treating stress and urge incontinence |
| US20090157091A1 (en) * | 2006-04-04 | 2009-06-18 | Ams Research Corporation | Apparatus for Implanting Neural Stimulation Leads |
| US20070265675A1 (en) * | 2006-05-09 | 2007-11-15 | Ams Research Corporation | Testing Efficacy of Therapeutic Mechanical or Electrical Nerve or Muscle Stimulation |
| US9480846B2 (en) | 2006-05-17 | 2016-11-01 | Medtronic Urinary Solutions, Inc. | Systems and methods for patient control of stimulation systems |
| US10322287B2 (en) | 2006-05-17 | 2019-06-18 | Medtronic Urinary Solutions, Inc. | Systems and methods for patient control of stimulation systems |
| US20100076254A1 (en) * | 2006-06-05 | 2010-03-25 | Ams Research Corporation | Electrical muscle stimulation to treat fecal incontinence and/or pelvic prolapse |
| US20080009914A1 (en) * | 2006-07-10 | 2008-01-10 | Ams Research Corporation | Systems and Methods for Implanting Tissue Stimulation Electrodes in the Pelvic Region |
| US20090012592A1 (en) * | 2006-07-10 | 2009-01-08 | Ams Research Corporation | Tissue anchor |
| US8160710B2 (en) | 2006-07-10 | 2012-04-17 | Ams Research Corporation | Systems and methods for implanting tissue stimulation electrodes in the pelvic region |
| AU2007254621B2 (en) * | 2006-12-21 | 2011-05-12 | Ams Research Corporation | Electrode implantation in male external urinary sphincter |
| US20080161876A1 (en) * | 2006-12-21 | 2008-07-03 | Ams Research Corporation | Electrode implantation in male external urinary sphincter |
| US7647113B2 (en) * | 2006-12-21 | 2010-01-12 | Ams Research Corporation | Electrode implantation in male external urinary sphincter |
| US20100049289A1 (en) * | 2007-07-10 | 2010-02-25 | Ams Research Corporation | Tissue anchor |
| US9427573B2 (en) | 2007-07-10 | 2016-08-30 | Astora Women's Health, Llc | Deployable electrode lead anchor |
| US8774942B2 (en) | 2007-07-10 | 2014-07-08 | Ams Research Corporation | Tissue anchor |
| US8594794B2 (en) | 2007-07-24 | 2013-11-26 | Cvrx, Inc. | Baroreflex activation therapy with incrementally changing intensity |
| US20090082828A1 (en) * | 2007-09-20 | 2009-03-26 | Alan Ostroff | Leadless Cardiac Pacemaker with Secondary Fixation Capability |
| US9393411B2 (en) | 2008-04-02 | 2016-07-19 | Case Western Reserve University | System and method of bladder and sphincter control |
| US9272155B2 (en) | 2009-02-02 | 2016-03-01 | Pacesetter, Inc. | Leadless cardiac pacemaker with secondary fixation capability |
| US8527068B2 (en) | 2009-02-02 | 2013-09-03 | Nanostim, Inc. | Leadless cardiac pacemaker with secondary fixation capability |
| US20100198288A1 (en) * | 2009-02-02 | 2010-08-05 | Alan Ostroff | Leadless Cardiac Pacemaker with Secondary Fixation Capability |
| USRE50564E1 (en) | 2009-02-02 | 2025-09-02 | Pacesetter, Inc. | Leadless cardiac pacemaker with secondary fixation capability |
| US20100217340A1 (en) * | 2009-02-23 | 2010-08-26 | Ams Research Corporation | Implantable Medical Device Connector System |
| US9539433B1 (en) | 2009-03-18 | 2017-01-10 | Astora Women's Health, Llc | Electrode implantation in a pelvic floor muscular structure |
| US20110077708A1 (en) * | 2009-09-28 | 2011-03-31 | Alan Ostroff | MRI Compatible Leadless Cardiac Pacemaker |
| US9550064B2 (en) | 2009-10-20 | 2017-01-24 | Adi Mashiach | Apparatus and methods for feedback-based nerve modulation |
| US8574164B2 (en) | 2009-10-20 | 2013-11-05 | Nyxoah SA | Apparatus and method for detecting a sleep disordered breathing precursor |
| US8577472B2 (en) | 2009-10-20 | 2013-11-05 | Nyxoah SA | Systems and methods for determining a sleep disorder based on positioning of the tongue |
| US8577464B2 (en) | 2009-10-20 | 2013-11-05 | Nyxoah SA | Apparatus and methods for feedback-based nerve modulation |
| US9409013B2 (en) | 2009-10-20 | 2016-08-09 | Nyxoah SA | Method for controlling energy delivery as a function of degree of coupling |
| US11273307B2 (en) | 2009-10-20 | 2022-03-15 | Nyxoah SA | Method and device for treating sleep apnea |
| US9415215B2 (en) | 2009-10-20 | 2016-08-16 | Nyxoah SA | Methods for treatment of sleep apnea |
| US9415216B2 (en) | 2009-10-20 | 2016-08-16 | Nyxoah SA | Devices for treatment of sleep apnea |
| US9943686B2 (en) | 2009-10-20 | 2018-04-17 | Nyxoah SA | Method and device for treating sleep apnea based on tongue movement |
| US8380312B2 (en) | 2009-12-31 | 2013-02-19 | Ams Research Corporation | Multi-zone stimulation implant system and method |
| US20110160793A1 (en) * | 2009-12-31 | 2011-06-30 | Ams Research Corporation | Multi-Zone Stimulation Implant System and Method |
| US9687655B2 (en) | 2010-10-12 | 2017-06-27 | Pacesetter, Inc. | Temperature sensor for a leadless cardiac pacemaker |
| US8543205B2 (en) | 2010-10-12 | 2013-09-24 | Nanostim, Inc. | Temperature sensor for a leadless cardiac pacemaker |
| US9060692B2 (en) | 2010-10-12 | 2015-06-23 | Pacesetter, Inc. | Temperature sensor for a leadless cardiac pacemaker |
| US9020611B2 (en) | 2010-10-13 | 2015-04-28 | Pacesetter, Inc. | Leadless cardiac pacemaker with anti-unscrewing feature |
| US10201702B2 (en) | 2010-11-30 | 2019-02-12 | Medtronic, Inc. | Pelvic floor muscle training |
| US12226122B2 (en) | 2010-12-13 | 2025-02-18 | Pacesetter, Inc. | Pacemaker retrieval systems and methods |
| US8615310B2 (en) | 2010-12-13 | 2013-12-24 | Pacesetter, Inc. | Delivery catheter systems and methods |
| US11759234B2 (en) | 2010-12-13 | 2023-09-19 | Pacesetter, Inc. | Pacemaker retrieval systems and methods |
| US11786272B2 (en) | 2010-12-13 | 2023-10-17 | Pacesetter, Inc. | Pacemaker retrieval systems and methods |
| US11890032B2 (en) | 2010-12-13 | 2024-02-06 | Pacesetter, Inc. | Pacemaker retrieval systems and methods |
| US9126032B2 (en) | 2010-12-13 | 2015-09-08 | Pacesetter, Inc. | Pacemaker retrieval systems and methods |
| US10188425B2 (en) | 2010-12-13 | 2019-01-29 | Pacesetter, Inc. | Pacemaker retrieval systems and methods |
| US9242102B2 (en) | 2010-12-20 | 2016-01-26 | Pacesetter, Inc. | Leadless pacemaker with radial fixation mechanism |
| US9220887B2 (en) | 2011-06-09 | 2015-12-29 | Astora Women's Health LLC | Electrode lead including a deployable tissue anchor |
| US9731112B2 (en) | 2011-09-08 | 2017-08-15 | Paul J. Gindele | Implantable electrode assembly |
| US9649493B2 (en) | 2011-09-30 | 2017-05-16 | Adi Mashiach | System and method for nerve modulation using noncontacting electrodes |
| US9248291B2 (en) | 2011-09-30 | 2016-02-02 | Adi Mashiach | Hypertension therapy implant apparatus |
| US9358392B2 (en) | 2011-09-30 | 2016-06-07 | Adi Mashiach | Electrode configuration for implantable modulator |
| US8577467B2 (en) | 2011-09-30 | 2013-11-05 | Nyxoah SA | Apparatus and method for controlling energy delivery as a function of degree of coupling |
| US8798773B2 (en) | 2011-09-30 | 2014-08-05 | Man & Science, SA | Electrode configuration for implantable modulator |
| US8577468B2 (en) | 2011-09-30 | 2013-11-05 | Nyxoah SA | Apparatus and method for extending implant life using a dual power scheme |
| US9421372B2 (en) | 2011-09-30 | 2016-08-23 | Adi Mashiach | Head pain management device having an antenna |
| US10828492B2 (en) | 2011-09-30 | 2020-11-10 | Adi Mashiach | Devices and methods for low current neural modulation |
| US8577465B2 (en) | 2011-09-30 | 2013-11-05 | Nyxoah SA | Modulator apparatus configured for implantation |
| US9314613B2 (en) | 2011-09-30 | 2016-04-19 | Adi Mashiach | Apparatus and methods for modulating nerves using parallel electric fields |
| US9878159B2 (en) | 2011-09-30 | 2018-01-30 | Adi Mashiach | Hypertension therapy implant apparatus |
| US8577466B2 (en) | 2011-09-30 | 2013-11-05 | Nyxoah SA | System and method for nerve modulation using noncontacting electrodes |
| US9895540B2 (en) | 2011-09-30 | 2018-02-20 | Nyxoah SA | Devices and methods for low current neural modulation |
| US9061151B2 (en) | 2011-09-30 | 2015-06-23 | Adi Mashiach | Apparatus and method to control an implant |
| US8718776B2 (en) | 2011-09-30 | 2014-05-06 | Nyxoah SA | Apparatus and method to control an implant |
| US8644957B2 (en) | 2011-09-30 | 2014-02-04 | Nyxoah SA | Electrode configuration for implantable modulator |
| US9302093B2 (en) | 2011-09-30 | 2016-04-05 | Nyxoah SA | Devices and methods for delivering energy as a function of condition severity |
| US9403009B2 (en) | 2011-09-30 | 2016-08-02 | Nyxoah SA | Apparatus and methods for implant coupling indication |
| US8989868B2 (en) | 2011-09-30 | 2015-03-24 | Hyllio SA | Apparatus and method for controlling energy delivery as a function of degree of coupling |
| US8577478B2 (en) | 2011-09-30 | 2013-11-05 | Nyxoah SA | Antenna providing variable communication with an implant |
| US9044612B2 (en) | 2011-09-30 | 2015-06-02 | Adi Mashiach | Apparatus and method for extending implant life using a dual power scheme |
| US8929999B2 (en) | 2011-09-30 | 2015-01-06 | Adi Maschiach | Electrode configuration for implantable modulator |
| US8588941B2 (en) | 2011-09-30 | 2013-11-19 | Nyxoah SA | Device and method for modulating nerves using parallel electric fields |
| US8700183B2 (en) | 2011-09-30 | 2014-04-15 | Nyxoah SA | Devices and methods for low current neural modulation |
| US9511236B2 (en) | 2011-11-04 | 2016-12-06 | Pacesetter, Inc. | Leadless cardiac pacemaker with integral battery and redundant welds |
| US11938330B2 (en) | 2012-08-01 | 2024-03-26 | Pacesetter, Inc. | Implantable leadless pacemakers |
| US10744332B2 (en) | 2012-08-01 | 2020-08-18 | Pacesetter, Inc. | Biostimulator circuit with flying cell |
| US11759646B2 (en) | 2012-08-01 | 2023-09-19 | Pacesetter, Inc. | Biostimulator circuit with flying cell |
| US9802054B2 (en) | 2012-08-01 | 2017-10-31 | Pacesetter, Inc. | Biostimulator circuit with flying cell |
| US12161858B2 (en) | 2013-01-21 | 2024-12-10 | Cala Health, Inc. | Devices and methods for controlling tremor |
| US9452287B2 (en) | 2013-01-21 | 2016-09-27 | Cala Health, Inc. | Devices and methods for controlling tremor |
| US10625074B2 (en) | 2013-01-21 | 2020-04-21 | Cala Health, Inc. | Devices and methods for controlling tremor |
| US12453853B2 (en) | 2013-01-21 | 2025-10-28 | Cala Health, Inc. | Multi-modal stimulation for treating tremor |
| US10850090B2 (en) | 2013-01-21 | 2020-12-01 | Cala Health, Inc. | Devices and methods for controlling tremor |
| US10173060B2 (en) | 2014-06-02 | 2019-01-08 | Cala Health, Inc. | Methods for peripheral nerve stimulation |
| US10179238B2 (en) | 2014-06-02 | 2019-01-15 | Cala Health, Inc. | Systems for peripheral nerve stimulation |
| US9802041B2 (en) | 2014-06-02 | 2017-10-31 | Cala Health, Inc. | Systems for peripheral nerve stimulation to treat tremor |
| US12109413B2 (en) | 2014-06-02 | 2024-10-08 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation to treat tremor |
| US10561839B2 (en) | 2014-06-02 | 2020-02-18 | Cala Health, Inc. | Systems for peripheral nerve stimulation |
| US10905879B2 (en) | 2014-06-02 | 2021-02-02 | Cala Health, Inc. | Methods for peripheral nerve stimulation |
| US10960207B2 (en) | 2014-06-02 | 2021-03-30 | Cala Health, Inc. | Systems for peripheral nerve stimulation |
| US10549093B2 (en) | 2014-06-02 | 2020-02-04 | Cala Health, Inc. | Method for peripheral nerve stimulation |
| US10765856B2 (en) | 2015-06-10 | 2020-09-08 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation to treat tremor with detachable therapy and monitoring units |
| US12157001B2 (en) | 2015-06-10 | 2024-12-03 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation to treat tremor with detachable therapy and monitoring units |
| US12420082B2 (en) | 2015-09-23 | 2025-09-23 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation in the finger or hand |
| US11596785B2 (en) | 2015-09-23 | 2023-03-07 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation in the finger or hand to treat hand tremors |
| US12357824B2 (en) | 2016-01-21 | 2025-07-15 | Cala Health, Inc. | Systems, methods and devices for peripheral neuromodulation |
| US11918806B2 (en) | 2016-01-21 | 2024-03-05 | Cala Health, Inc. | Systems, methods and devices for peripheral neuromodulation of the leg |
| US11344722B2 (en) | 2016-01-21 | 2022-05-31 | Cala Health, Inc. | Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder |
| US10814130B2 (en) | 2016-07-08 | 2020-10-27 | Cala Health, Inc. | Dry electrodes for transcutaneous nerve stimulation |
| US12233265B2 (en) | 2016-08-25 | 2025-02-25 | Cala Health, Inc. | Systems and methods for treating cardiac dysfunction through peripheral nerve stimulation |
| US10610685B2 (en) * | 2016-12-21 | 2020-04-07 | University Of Southern California | Smooth muscle electrical stimulation based on entrainment of intracellular calcium ion oscillations |
| US20180169409A1 (en) * | 2016-12-21 | 2018-06-21 | University Of Southern California | Smooth muscle electrical stimulation based on entrainment of intracellular calcium ion oscillations |
| US12161865B2 (en) | 2017-04-03 | 2024-12-10 | Cala Health, Inc. | Systems, methods and devices for peripheral neuromodulation |
| US11331480B2 (en) | 2017-04-03 | 2022-05-17 | Cala Health, Inc. | Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder |
| US11857778B2 (en) | 2018-01-17 | 2024-01-02 | Cala Health, Inc. | Systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation |
| US12251560B1 (en) | 2019-08-13 | 2025-03-18 | Cala Health, Inc. | Connection quality determination for wearable neurostimulation systems |
| US11890468B1 (en) | 2019-10-03 | 2024-02-06 | Cala Health, Inc. | Neurostimulation systems with event pattern detection and classification |
Also Published As
| Publication number | Publication date |
|---|---|
| GB1434524A (en) | 1976-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3870051A (en) | Urinary control | |
| US6937904B2 (en) | System and method for providing recovery from muscle denervation | |
| US3667477A (en) | Implantable vesical stimulator | |
| US6990376B2 (en) | Methods and systems for selective control of bladder function | |
| US6731979B2 (en) | Pulse width cardiac pacing apparatus | |
| US6659936B1 (en) | Method and apparatus for treating incontinence | |
| US5464429A (en) | Apparatus for producing heart defibrillation sequences from stimulation pulses and defibrillation shocks | |
| Tanagho et al. | Electrical stimulation in the clinical management of the neurogenic bladder | |
| AU745744B2 (en) | Implantable stimulator system and method for treatment of urinary incontinence | |
| EP0977615B1 (en) | Apparatus for administering microcurrent electrotherapy | |
| CA2120818A1 (en) | Regenerative Electrical Stimulator | |
| AU5669200A (en) | Electrical stimulation system and methods for treating phantom limb pain and forproviding sensory feedback to an amputee from a prosthetic limb | |
| Haas et al. | Neural Stimulation Circuits | |
| Perkins | Versatile three-channel stimulation controller for restoration of bladder function in paraplegia | |
| Benvenuto et al. | Emergency management of pacemaker failure by means of radio-frequency energy | |
| AU2005204340B2 (en) | Method and apparatus for treating incontinence | |
| AU781755B2 (en) | Method and apparatus for treating incontinence | |
| Stoehr et al. | Application of gate arrays in implants for nerve stimulation (remobilization of paraplegic patients) | |
| Lachance | Computerized Transcutaneous Control of a Multichannel Implantable Urinary Prosthesis |